Investor's Business Daily on MSN

Dow Jones futures: Stock market fades from highs; Eli Lilly, Google lead new buys

Dow Jones futures were little changed after hours, along with S&P 500 futures and Nasdaq futures.The stock market rally was ...
Investor's Business Daily on MSN

Eli Lilly, IBD stock of the day, offers two entries on rumored buyout rally

Eli Lilly is Wednesday's IBD Stock Of The Day. Shares are breaking above a pair of bases as rumors swirl about a potential ...

Palisade Flat on Crohn’s Investment

Palisade Bio, Inc. (NASDAQ: PALI) shares barely cleared breakeven Wednesday. The company, a clinical-stage biopharmaceutical ...
The Manila Times

Palisade Bio Announces Strategic Equity Investment from the Crohn’s & Colitis Foundation’s IBD Ventures Program to Advance PALI-2108

PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing significant unmet needs in ulcerative colitis (UC) and fibroste ...